KRAS / RAS targeting: from platform to Phase 3
Newly presented #AACR26 miPEP133 emerges as a potential tumor suppressor in #ovariancancer. Restoring its expression slowed tumor cell growth and increased sensitivity to chemotherapy and MEK inhibitors.
@AACR
@SmilowCancer
@OncoAlert
Heat 14 · 8 likes · 1 reply · 5 reposts
Ahmad A. Tarhini, Monica Chen, Jia Liu, Varun Monga, Victoria Atkinson, Sarina A. Piha-Paul, Bartosz Chmielowski, Benjamin Herzberg, Charlotte Lemech, Prachi Bhave, Ganessan Kichenadasse, Gerald Falchook, Janice Mehnert, Andrae Vandross, Mohamad Salkeni, Meredith McKean, David Wages, Ann Marie Kennedy, Meagan B. Ryan, John Clark, Abdulaziz Nanah, Michael J. Fossler, Philip Komarnitsky, Igor Puzanov
Read the abstract →Source: Yale Cancer Center · x.com